CORRESP Filing
Can-Fite BioPharma Ltd.
Date: July 24, 2025 · CIK: 0001536196 · Accession: 0001213900-25-067308
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-288890
Letter
Re: Can-Fite BioPharma Ltd.
July 24, 2025
VIA FACSIMILE AND EDGAR
U.S. Securities and Exchange Commission
Division of Corporate Finance
Washington, DC 20549
Registration Statement on Form S-1 (Registration No. 333-288890)
Concurrence in Acceleration Request
Ladies and Gentlemen:
H.C. Wainwright & Co., LLC (" Wainwright "), solely acting as placement agent on a best-efforts basis in an offering pursuant to the registration statement on Form S-1 (333-288890) (the " Registration Statement "), hereby concurs in the request by Can-Fite BioPharma Ltd. that the effective date of the above-referenced registration statement be accelerated to 9:00 A.M. Eastern Time on Monday, July 28, 2025, or as soon as practicable thereafter, pursuant to Rule 461 under the Securities Act. Wainwright affirms that it is aware of its obligations under the Securities Act as they pertain to the best efforts offering pursuant to the Registration Statement.
Very truly yours,
H.C. WAINWRIGHT & CO., LLC
Show Raw Text
CORRESP
1
filename1.htm
July 24, 2025
VIA FACSIMILE AND EDGAR
U.S. Securities and Exchange Commission
Division of Corporate Finance
Washington, DC 20549
Re: Can-Fite BioPharma
Ltd.
Registration Statement on Form S-1 (Registration
No. 333-288890)
Concurrence in Acceleration Request
Ladies and Gentlemen:
H.C. Wainwright & Co., LLC
(" Wainwright "), solely acting as placement agent on a best-efforts basis in an offering pursuant to the registration
statement on Form S-1 (333-288890) (the " Registration Statement "), hereby concurs in the request by Can-Fite BioPharma
Ltd. that the effective date of the above-referenced registration statement be accelerated to 9:00 A.M. Eastern Time on Monday, July 28,
2025, or as soon as practicable thereafter, pursuant to Rule 461 under the Securities Act. Wainwright affirms that it is aware of its
obligations under the Securities Act as they pertain to the best efforts offering pursuant to the Registration Statement.
Very truly yours,
H.C. WAINWRIGHT & CO., LLC
By:
/s/ Edward D. Silvera
Name:
Edward D. Silvera
Title:
Chief Operating Officer